Lab Services
Forecast Recompete Updated
- Agency
-
Indian Health Service
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Incumbent contract
-
- 75H70926P00059 Federal contract award held by The American National Red Cross Ends Mar 31, 2029 · Value with all options $42,000
- Anticipated award
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Indian Health Service is recompeting a blood products and immunohematological services contract, with solicitation release estimated for January 1, 2027 and award targeted for April 1, 2027. The procurement seeks in-vitro diagnostic substance manufacturing capabilities, classified under NAICS 325413, with no small business set-aside applied.
The estimated award value ranges from $25,000 to $250,000. Performance occurs at the Browning, Montana location. Andrew Baughn (andrew.baughn@ihs.gov) and Contracting Officer DeeAndra Salabye (deeandra.salabye@ihs.gov, 406-208-8857) are the points of contact.
The incumbent award, Purchase Order 75H70926P00059, was issued to The American National Red Cross on April 1, 2026, as a firm fixed-price contract valued at $42,000 with ultimate completion on March 31, 2029. The order covers blood, blood products, and immunohematological services supporting healthcare operations.
Forecast text
Redcross_Blood product/units
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast